Britain’s biggest drugmaker AstraZeneca announced on June 28 that it would invest $400 million to plant over 200 million trees by 2030 as part of its strategy for reducing carbon emissions in accordance with the Paris Agreement.
The commitment represents about $60 million a year, for one of the UK's most valuable listed companies, which has a market capitalization of about $230 billion. AstraZeneca’s revenue in 2022 was about $44 billion.
